Physician profile
Emad Ibrahim
NPI 1467716183
$84,715.86
in general payments reported to CMS, 2019-2025
18 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66K · 2020: $17K · 2021: $209 · 2022: $504 · 2023: $350 · 2024: $491 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,031.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $82,709.71 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $609.74 | 2019-2024 | Xiaflex, Aveed |
| Coloplast Corp | $346.34 | 2021-2023 | Titan |
| Ambu INC. | $224.44 | 2024 | |
| Axonics, INC. | $184.89 | 2022-2024 | Axonics |
| Boston Scientific Corporation | $124.66 | 2019-2025 | Ams 700, Advance Xp |
| Telix Pharmaceuticals | $83.57 | 2025 | Illuccix |
| Acerus Pharmaceuticals Corporation | $79.91 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $79.52 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $50.00 | 2023 | Xyosted, Tlando |
| Endo USA, INC. | $43.50 | 2024 | Xiaflex |
| Astellas Pharma US INC | $38.44 | 2019 | |
| Ferring Pharmaceuticals INC. | $35.83 | 2019 | |
| Dendreon Pharmaceuticals LLC | $27.30 | 2025 | Provenge |
| Progenics Pharmaceuticals, INC. | $24.40 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $20.07 | 2022 | |
| Abbvie INC. | $18.04 | 2024 | |
| Novartis Pharmaceuticals Corporation | $15.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emad Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.